RAYMOND JAMES & ASSOCIATES - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 251 filers reported holding NOVAVAX INC in Q3 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of NOVAVAX INC
ValueSharesWeighting
Q3 2023$1,020,616
+20.4%
140,969
+755.1%
0.00%0.0%
Q2 2022$848,000
+78.5%
16,485
+396.2%
0.00%
Q4 2021$475,000
-42.2%
3,322
-16.2%
0.00%
-100.0%
Q3 2021$822,000
-26.3%
3,966
-24.6%
0.00%0.0%
Q2 2021$1,116,000
-14.7%
5,258
-27.2%
0.00%0.0%
Q1 2021$1,309,000
+40.6%
7,218
-13.6%
0.00%0.0%
Q4 2020$931,000
-3.0%
8,353
-5.7%
0.00%0.0%
Q3 2020$960,000
-4.5%
8,859
-26.6%
0.00%0.0%
Q2 2020$1,005,000
+392.6%
12,062
-19.5%
0.00%
Q1 2020$204,000
+334.0%
14,992
+26.4%
0.00%
Q4 2019$47,00011,8620.00%
Other shareholders
NOVAVAX INC shareholders Q3 2022
NameSharesValueWeighting ↓
HELLMAN JORDAN MANAGEMENT CO INC /MA/ 50,910$5,516,00010.50%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 297,400$32,223,0004.94%
Ikarian Capital, LLC 375,400$40,675,0002.94%
TSP Capital Management Group, LLC 60,075$6,509,0002.66%
RA Capital Management 1,198,602$129,869,0002.38%
Foresite Capital Management I, LLC 66,810$7,239,0002.04%
Healthcare Value Capital, LLC 5,000$542,0001.79%
Rock Springs Capital Management LP 585,705$63,461,0001.61%
Foresite Capital Management II, LLC 67,373$7,300,0001.59%
BERYLSON CAPITAL PARTNERS, LLC 30,104$3,262,0001.14%
View complete list of NOVAVAX INC shareholders